A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer ...

Based on Cisbio Bioassays' patented HTRF® technology, HTRF Transcreener® ADP assay is a universal method for identifying and characterizing the phosphotransferase activity of ATPases and kinases.

The optimized immunoassay delivered impressive results. The detection limit was significantly lower than traditional methods, with a linear detection range for β-PV concentrations spanning 25 ng ...

The NoShift Transcription Factor Assay Kit provides a rapid and sensitive method for the identification of proteins that bind to DNA sequences. The developer of the assay, EMD Biosciences ...